Meet Alfa Cytology at the Cancer R&D 2024, Nov 18-20, 2024. We look forward to connecting with you and providing expert solutions for your cancer drug development projects.
Learn MoreExosomes are small extracellular vesicles that are released by various cell types, including but not limited to, immune cells, stem cells, and cancer cells with a diameter ranging from 30 to 150 nanometers. Exosomes have gained significant attention as potential sources of biomarkers for bladder cancer. Alfa Cytology offers comprehensive exosome-based analysis services for you.
Exosomes play important roles in intercellular communication by transferring various biomolecules, such as proteins, nucleic acids (including RNA and DNA), lipids, and metabolites, between cells. Exosomes and their contents can regulate cell proliferation, cell cycle, invasion and migration, metastasis, angiogenesis and cisplatin chemoresistance in bladder cancer.
Fig.1 The signaling pathways involved in exosomes regulating bladder cancer progression. (Yang, Y., et al. 2023)
To further advance the investigation and application of exosomes in bladder cancer, the development of imaging and visualization studies to track exosomes is necessary. Tracing the movement and interactions of exosomes can help researchers understand their roles in tumor progression and identify potential diagnostic or therapeutic targets.
In vivo tracing of isolated exosomes is helpful for further studies on the functions and applications of exosomes. At Alfa Cytology, we provide exosome tracking service enabling real-time monitoring and visualization of the dynamic distribution and functionality of exosomes within living organisms, supporting customers in acquiring profound insights into the intricate mechanisms of exosomes in biological processes.
Visualizing Methods | Reporters | Advantages | Applications |
---|---|---|---|
Bioluminescence Imaging (BLI) | Gaussia-luciferase (Gluc) |
|
In Vivo and ex Vivo |
Magnetic Resonance Imaging (MRI) | SPIONs, USPIO |
|
In Vivo |
Computed Tomography (CT) | Gold Nanoparticles (GNPs) |
|
In Vivo |
Nuclear Imaging | Radioisotopes |
|
In Vivo |
Photoacoustic Imaging | Graphene Quantum Dot Nanozyme |
|
In Vivo and ex Vivo |
GNPs | |||
Fluorescence Imaging | Organic Dyes |
|
In Vitro |
GNPs | In Vivo and ex Vivo | ||
Aggregation-induced Emission Luminogens (AIEgens) | In Vivo and ex Vivo | ||
Genetically Encoded Fluorescent Proteins | In Vivo and ex Vivo | ||
Immunofluorescent Reporters | In Vitro | ||
Quantum Dots (Qdots) | In Vivo and ex Vivo |
Exosome Extraction and Purification
Exosome Concentration Determination
Exosome Fluorescent Labeling
Fluorescence Exosome Purification
Imaging Observation
If you are interested in our exosome tracer services for bladder cancer research or have any inquiries, please feel free to contact us. Our dedicated team is ready to provide you with further information and discuss how we can support your research goals. Together, we can accelerate the development of early diagnosis and therapeutic strategies for bladder cancer.
Reference
Alfa Cytology is dedicated to drug development and preclinical services for bladder cancer.